Arrowstreet Capital, Limited Partnership Bristol Myers Squibb CO Transaction History
Arrowstreet Capital, Limited Partnership
- $108 Billion
- Q1 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 3,331,575 shares of BMY stock, worth $138 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
3,331,575
Previous 491,267
578.16%
Holding current value
$138 Million
Previous $25.2 Million
616.75%
% of portfolio
0.17%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding BMY
# of Institutions
2,554Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.73 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.75 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.8 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.69 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.92 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $88.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...